The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury

被引:14
|
作者
Zhou, Ping [1 ,2 ]
Zhang, Shun [1 ,2 ]
Wang, Maohua [1 ,2 ]
Zhou, Jun [1 ,2 ]
机构
[1] Southwest Med Univ, Dept Anesthesiol, Affiliated Hosp, Luzhou 646000, Peoples R China
[2] Anesthesiol & Crit Care Med Key Lab Luzhou, Luzhou 646000, Peoples R China
基金
中国国家自然科学基金;
关键词
ferroptosis; necroptosis; pyroptosis; inflammatory bowel disease; colorectal cancer; intestinal injury; CELL-DEATH; EXPERIMENTAL COLITIS; LIPID-PEROXIDATION; GASDERMIN D; ACTIVATION; PATHWAY; INHIBITION; TRIGGERS; NLRP3; CHEMOSENSITIVITY;
D O I
10.3390/biom13050820
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell death includes programmed and nonprogrammed cell death. The former mainly includes ferroptosis, necroptosis, pyroptosis, autophagy, and apoptosis, while the latter refers to necrosis. Accumulating evidence shows that ferroptosis, necroptosis, and pyroptosis play essential regulatory roles in the development of intestinal diseases. In recent years, the incidence of inflammatory bowel disease (IBD), colorectal cancer (CRC), and intestinal injury induced by intestinal ischemia-reperfusion (I/R), sepsis, and radiation have gradually increased, posing a significant threat to human health. The advancement in targeted therapies for intestinal diseases based on ferroptosis, necroptosis, and pyroptosis provides new strategies for treating intestinal diseases. Herein, we review ferroptosis, necroptosis, and pyroptosis with respect to intestinal disease regulation and highlight the underlying molecular mechanisms for potential therapeutic applications.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer
    Ma, Yongshun
    Zhang, Yao
    Xiang, Jianghou
    Xiang, Shixin
    Zhao, Yueshui
    Xiao, Mintao
    Du, Fukuan
    Ji, Huijiao
    Kaboli, Parham Jabbarzadeh
    Wu, Xu
    Li, Mingxing
    Wen, Qinglian
    Shen, Jing
    Yang, Zhongmin
    Li, Jing
    Xiao, Zhangang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [42] Colorectal cancer in inflammatory bowel disease: a shift in risk?
    Gallinger, Zane R.
    Weizman, Adam V.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (07) : 847 - 856
  • [43] Colorectal cancer in inflammatory bowel disease: review of the evidence
    Keller, D. S.
    Windsor, A.
    Cohen, R.
    Chand, M.
    TECHNIQUES IN COLOPROCTOLOGY, 2019, 23 (01) : 3 - 13
  • [44] Colorectal cancer risk in patients with inflammatory bowel disease
    Keller, R
    Fischbach, W
    LEBER MAGEN DARM, 2000, 30 (01) : 14 - 20
  • [45] Management of colorectal cancer in patients with inflammatory bowel disease
    D. O. Kavanagh
    M. C. Carter
    D. Keegan
    G. Doherty
    M. J. Smith
    J. M. P. Hyland
    H. Mulcahy
    K. Sheahan
    P. R. O’ Connell
    D. P. O’ Donoghue
    D. C. Winter
    Techniques in Coloproctology, 2014, 18 : 23 - 28
  • [46] Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer
    Zhen-Yang Gu
    Wen-Long Pei
    Yi Zhang
    Jun Zhu
    Lei Li
    Zhan Zhang
    中华医学杂志英文版, 2021, 134 (23) : 2841 - 2843
  • [47] Dysplasia and colorectal cancer surveillance in inflammatory bowel disease
    Pulusu, Samba Siva Reddy
    Lawrance, Ian C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (08) : 711 - 722
  • [48] Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease
    Masakazu Yashiro
    Digestive Diseases and Sciences, 2015, 60 : 2251 - 2263
  • [49] COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE - IS SURVEILLANCE WORKING?
    Akbar, T.
    Rahmany, S.
    Harris, R.
    Cotton, S.
    McCabe, L-A
    Lloyd, D. A.
    Gordon, J. N.
    GUT, 2015, 64 : A442 - A442
  • [50] Mesalazine and the prevention of colorectal cancer in inflammatory bowel disease
    Bos, C. L.
    Richel, D. J.
    Peppelenbosch, M. P.
    INTESTINAL INFLAMMATION AND COLORECTAL CANCER, 2007, 158 : 226 - 235